These findings indicated that the impact of PCSK9 on the risks of IS might be of more complexity; unlike homogenous phenotype in CHD, IS involves etiological heterogeneity with different subtypes (such as large artery atherosclerosis, cardioembolic embolism, and small vessel disease) (59). This evidence concerns the gene PCSK9 and coronary artery disorder.